Hong Kong plans ‘to overtake Nasdaq’ as listing destination of choice for Chinese biotech firms

Wall Street cheers Hong Kong’s IPO rules revamp but sees New York’s dominance unthreatened Meanwhile, asked if the Shanghai bourse’s plan to allow non-mainland listed firms to issue shares traded in the mainland via the so-called Chinese Depository …
( read original story …)


Related Post

Wheelock and HK science park team up to offer free...
views 7
Hong Kong start-ups are being given the chance to ...
What to expect when public consultation begins to ...
views 7
To solve Hong Kong’s housing shortage, would you p...
Hong Kong schools waiting too long to identify spe...
views 5
One in three Hong Kong pupils identified to have l...
Taiwan biotech firm eyes Hong Kong IPO for push in...
views 15
ACRO Biomedical, a Taiwan-based developer of skin,...
Hong Kong Bank Customers Ready to Embrace Artifici...
views 15
Hong Kong consumers willing to allow banks to shar...
Plan for new ‘Hong Kong Town’ in mainl...
views 16
Hong Kong's housing prices are among the world's m...
Hong Kong conglomerate Goldin Financial’s stock so...
views 19
Hong Kong conglomerate Goldin Financial Holdings p...
Big Bang Means Buyer Beware in Hong Kong IPOs
views 17
Other likely candidates include smartphone maker X...
Bank of China HK uses blockchain in almost all rea...
views 16
Blockchain is at the core of the Bank of China Hon...
Linklaters signs up Goldman Sachs Asia disputes sp...
views 18
The hire marks a relatively rare lateral addition ...